Standout Papers

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs 2020 2026 2022 2024439
  1. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs (2020)
    Sangeun Jeon, Meehyun Ko et al. Antimicrobial Agents and Chemotherapy

Immediate Impact

4 from Science/Nature 52 standout
Sub-graph 1 of 23

Citing Papers

mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
10 intermediate papers

Works of Meehyun Ko being referenced

An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus
2019
Viral Genome Methylation Differentially Affects the Ability of BZLF1 versus BRLF1 To Activate Epstein-Barr Virus Lytic Gene Expression and Viral Replication
2012

Author Peers

Author Last Decade Papers Cites
Meehyun Ko 488 179 69 142 12 728
Soo Young Byun 340 156 80 121 8 577
Md Sorwer Alam Parvez 448 169 62 73 15 689
Takao Sanaki 405 159 73 65 26 671
Jianyong Zhu 389 136 65 48 15 667
Shih-Hwa Chiou 384 188 32 71 11 650
Ysrafil Ysrafil 508 234 39 111 17 789
Junwen Luan 337 142 31 72 15 595
Oliver Pilgram 496 178 63 67 8 676
Kirstin Mösbauer 391 189 147 71 5 662
Shweta Jakhmola 264 183 64 40 23 661

All Works

Loading papers...

Rankless by CCL
2026